Mirabella, Massimiliano http://orcid.org/0000-0002-7783-114X
Prosperini, Luca
Lucchini, Matteo
Boffa, Laura
Borriello, Giovanna
Buscarinu, Maria Chiara
Centonze, Diego
Cortese, Antonio
De Fino, Chiara
De Giglio, Laura
Elia, Giorgia
Fantozzi, Roberta
Ferraro, Elisabetta
Francia, Ada
Galgani, Simona
Gasperini, Claudio
Haggiag, Shalom
Landi, Doriana
Marfia, Girolama Alessandra
Millefiorini, Enrico
Monteleone, Fabrizia
Nociti, Viviana
Salvetti, Marco
Sgarlata, Eleonora
Pozzilli, Carlo
Article History
First Online: 18 July 2018
Compliance with Ethical Standards
:
: No sources of funding were used to conduct this study or prepare this manuscript.
: MM is or has been a member of scientific advisory boards for Bayer Schering, Biogen, Sanofi-Genzyme, Merck, Novartis, Teva; has received consulting and/or speaking fees, research support or travel grants from Almirall, Bayer Schering, Biogen, CSL Behring, Sanofi-Genzyme, Merck, Novartis, Teva, Roche, Ultragenix; and has acted as principal investigator in clinical trials for Biogen, Merck, Novartis, Roche, Sanofi-Genzyme, Teva, Ultragenix. LP has received consulting fees from Biogen, Novartis and Roche; speaker honoraria from Biogen, Genzyme, Merck, Novartis and Teva; travel grants from Biogen, Genzyme, Novartis and Teva; and research grants from the Italian MS Society (Associazione Italiana Sclerosi Multipla) and Genzyme. ML has received travel grants from Biogen and Sanofi-Genzyme and speaker honoraria from Biogen. GB has received consulting fees from Merck and Roche and speaker honoraria from Bayer Schering, Biogen, Teva and Novartis. DC is a member of advisory boards for Almirall, Bayer Schering, Biogen, Genzyme, GW Pharmaceuticals, Merck, Novartis and Teva and has received honoraria for speaking or consultation fees from Almirall, Bayer Schering, Biogen Idec, Genzyme, GW Pharmaceuticals, Merck, Novartis, Sanofi and Teva. He has also been the principal investigator in clinical trials for Bayer Schering, Biogen Idec, Merck, Mitsubishi, Novartis, Roche, Sanofi and Teva. His preclinical and clinical research was supported by grants from Bayer, Biogen, Merck, Novartis and Teva. AC has received honoraria for speaking and travel grants from Biogen, Sanofi-Genzyme and Teva. LDG has received travel grants from Biogen, Novartis and Teva. RF has received honoraria for speaking or consultation fees from Almirall, Merck, Novartis, Sanofi, Teva and Biogen and payments for advisory board membership from Teva, Biogen, Merck and Novartis. EF has received honoraria for advisory board membership and/or travel grants from Merck, Sanofi-Genzyme and Teva. SG has received speaker fees or travel expenses for attending meetings from Biogen, Merck, Teva, Almirall, Sanofi Aventis, Novartis and Genzyme. CG has received speaker fees or travel expenses for attending meetings from Biogen, Merck, Teva, Sanofi, Novartis and Genzyme. CP has served on scientific advisory boards for Actelion, Biogen, Genzyme, Hoffmann La Roche Ltd, Merck, Novartis, Sanofi and Teva and has received consulting and/or speaking fees, research support and travel grants from Allergan, Almirall, Biogen, Genzyme, Hoffmann La Roche Ltd, Merck, Novartis, Sanofi and Teva. GAM is or has been a member of advisory boards for Biogen, Genzyme, Merck, Novartis and Teva and has received honoraria for speaking or consultation fees from Almirall, Bayer Schering, Biogen Idec, Genzyme, Merck, Novartis and Teva. He is or has been the principal investigator in clinical trials for Actelion, Biogen Idec, Merck, Mitsubishi, Novartis, Roche, Sanofi and Teva. VN has received honoraria for speaking, advisory board membership and consulting from Teva, Sanofi-Genzyme, Almirall, Biogen, Bayer Schering, Merck and Novartis. MS has received consulting fees and/or honoraria for speakingĀ and/or research grants from Biogen, Genzyme, Merck Serono, Novartis, Roche, and Teva. GE, CDF, LB, FM, ES, MCB, AF, SH, DL, EM have no conflicts of interest.